|
 |
|
Content page upper right links
|
|
 |
Mechanical | Material Sci | Electronic | Software | Chemical | Biotech | Medical Dev | Pharmaceutical
Recent Biotech Patents written by SLW
|
|
PAT. NO.
|
Title
|
|
1
|
6,673,901
|
Artificial antibody polypeptides
|
|
2
|
6,673,561
|
Diagnostic test for thrombotic or thromboembolic disease
|
|
3
|
6,667,302
|
Heterocyclic topoisomerase poisons
|
|
4
|
6,663,881
|
Therapeutic inhibitor of vascular smooth muscle cells
|
|
5
|
6,656,926
|
Phosphoramide compounds
|
|
6
|
6,656,684
|
Method for predicting tumor recurrence
|
|
7
|
6,635,803
|
Method to improve drought tolerance in plants
|
|
8
|
6,635,466
|
Adenovirus serotype 30 (Ad30)
|
|
9
|
6,635,163
|
Entropic trapping and sieving of molecules
|
|
10
|
6,632,605
|
Hybridization assays on oligonucleotide arrays
|
|
11
|
6,624,342
|
Manipulation of tocopherol content in transgenic plants
|
|
12
|
6,620,810
|
4-thioxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents
|
|
13
|
6,613,531
|
Sigma binding region of RNA polymerase and uses thereof
|
|
14
|
6,610,301
|
Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines
|
|
15
|
6,602,693
|
Gene encoding hyaluronan synthase
|
|
16
|
6,602,677
|
Thermostable luciferases and methods of production
|
|
17
|
6,600,029
|
Metabolic engineering of polyhydroxyalkanoate monomer synthases
|
|
18
|
6,599,935
|
Felbamate derived compounds
|
|
19
|
6,599,928
|
Therapeutic inhibitor of vascular smooth muscle cells
|
|
20
|
6,596,856
|
Nucleic acid labeling compounds
|
|
21
|
6,585,981
|
Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
|
|
22
|
6,571,122
|
Implantable medical device responsive to heart rate variability analysis
|
|
23
|
6,571,121
|
Implantable medical device responsive to heart rate variability analysis
|
|
24
|
6,569,441
|
Therapeutic inhibitor of vascular smooth muscle cells
|
|
25
|
6,566,515
|
Photocleavable protecting groups and methods for their use
|
|
26
|
6,562,819
|
Compounds for inhibition of ceramide-mediated signal transduction
|
|
27
|
6,559,474
|
Method for topographical patterning of materials
|
|
28
|
6,552,179
|
Mutant luciferases
|
|
29
|
6,548,796
|
Confocal macroscope
|
|
30
|
6,545,140
|
DNA encoding an avian beta-defensin and uses thereof
|
|
31
|
6,545,002
|
Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors
|
|
32
|
6,537,758
|
Method for isolating nucleic acid from micronuclei separated from a cell
|
|
33
|
6,524,812
|
Genes encoding resistance to DNA alkylating agents
|
|
34
|
6,518,400
|
Polynucleotide encoding a protein involved in chromosomal inheritance and method of use therefor
|
|
35
|
6,518,037
|
Two-component system that controls bacterial membrane synthesis
|
|
36
|
6,515,009
|
Therapeutic inhibitor of vascular smooth muscle cells
|
|
37
|
6,509,019
|
Immunologically active proteins from Borrelia burgdorferi
|
|
38
|
6,495,683
|
4-oxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents
|
|
39
|
6,495,661
|
DNA encoding the outer membrane protein of Pasteurella multocida
|
|
40
|
6,495,348
|
Mitomycin biosynthetic gene cluster
|
|
41
|
6,491,938
|
Therapeutic inhibitor of vascular smooth muscle cells
|
|
42
|
6,489,462
|
Sugarcane bacilliform virus promoter
|
|
43
|
6,488,760
|
Universal paint tinting concentrates
|
|
44
|
6,486,287
|
Functionalized silicon compounds and methods for their synthesis and use
|
|
45
|
6,486,286
|
Use of hexahydrolupulones as antibacterial agents
|
|
46
|
6,486,167
|
Heterocyclic cytotoxic agents
|
|
47
|
6,485,722
|
Method for selective engraftment of drug-resistant hematopoietic stem cells
|
|
48
|
6,479,263
|
Method for detection of micrometastatic prostate cancer
|
|
49
|
6,475,512
|
Process for improving glucose metabolism, satiety, and nutrient absorption in companion animals
|
|
|
 
|
|
